The Revitalize Expert
iCell Research Institute, Thailand
Since the establishment in 2012, iCell Research Institute (iCell Group) has been devoted to advancing innovative cell technologies to treat a wide range of diseases and injuries. Our institute focuses on developing therapeutic methods and alleviation techniques using cutting-edge stem cell technologies, operated under internationally recognized standard stem cell laboratory conditions.
At iCell, we embrace a multidisciplinary approach, integrating scientific, academic, and medical expertise to revolutionize treatment through personalized cellular therapies.
Beyond disease treatment, iCell Research Institute is deeply engaged in the study of anti-aging medicine aimed at enhancing overall health, extending human lifespan, and improving quality of life.
Our ongoing research emphasizes the development of therapies based on Mesenchymal Stem Cells (MSCs) - a cornerstone of next-generation medicine.
In the near future, our advanced methodologies will accelerate the commercialization of stem cell-based medical technologies, including cell isolation, cultivation, cryogenic preservation, and post-treatment prognosis analysis.
iCell Research Institute is committed to promoting regenerative medicine research under international standards, providing new solutions for degenerative diseases such as:
Neurological degeneration
Cartilage and joint degeneration
Vascular aging
Autoimmune disorders
Skin aging and degeneration
We are especially focused on rejuvenation therapy to restore vitality and improve systemic health. Additionally, our R&D team explores novel biomaterials for skin regeneration and stem cell-based cosmetics.
Thanachai Taka, Ph.D.
Chief Science Officer
iCell Research Institute, Thailand
MakeWebEasy